191 related articles for article (PubMed ID: 27925847)
1. Effectiveness of hepatitis A vaccination as post-exposure prophylaxis.
Parrón I; Planas C; Godoy P; Manzanares-Laya S; Martínez A; Sala MR; Minguell S; Torner N; Jané M; Domínguez A;
Hum Vaccin Immunother; 2017 Feb; 13(2):423-427. PubMed ID: 27925847
[TBL] [Abstract][Full Text] [Related]
2. Field effectiveness of hepatitis A vaccine and uptake of post exposure prophylaxis following a change to the Australian guidelines.
Freeman E; Lawrence G; McAnulty J; Tobin S; MacIntyre CR; Torvaldsen S
Vaccine; 2014 Sep; 32(42):5509-13. PubMed ID: 25111168
[TBL] [Abstract][Full Text] [Related]
3. Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel.
Nelson NP; Link-Gelles R; Hofmeister MG; Romero JR; Moore KL; Ward JW; Schillie SF
MMWR Morb Mortal Wkly Rep; 2018 Nov; 67(43):1216-1220. PubMed ID: 30383742
[TBL] [Abstract][Full Text] [Related]
4. Use of hepatitis A vaccine for post-exposure prophylaxis in individuals over 40 years of age: A systematic review of published studies and recommendations for vaccine use.
Link-Gelles R; Hofmeister MG; Nelson NP
Vaccine; 2018 May; 36(20):2745-2750. PubMed ID: 29673941
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of hepatitis A vaccine in post-exposure prophylaxis, The Netherlands, 2004-2012.
Whelan J; Sonder GJ; Bovée L; Speksnijder A; van den Hoek A
PLoS One; 2013; 8(10):e78914. PubMed ID: 24147144
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Measles Vaccination and Immune Globulin Post-Exposure Prophylaxis in an Outbreak Setting-New York City, 2013.
Arciuolo RJ; Jablonski RR; Zucker JR; Rosen JB
Clin Infect Dis; 2017 Nov; 65(11):1843-1847. PubMed ID: 29028959
[TBL] [Abstract][Full Text] [Related]
7. Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico.
Carlos F; Gómez JA; Anaya P; Romano-Mazzotti L
Hum Vaccin Immunother; 2016; 12(1):52-63. PubMed ID: 26503702
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis A outbreaks in the vaccination era in Catalonia, Spain.
Martínez A; Broner S; Torner N; Godoy P; Batalla J; Alvarez J; Barrabeig I; Camps N; Carmona G; Minguell S; Sala R; Caylà J; Domínguez A
Hum Vaccin; 2011; 7 Suppl():205-10. PubMed ID: 21285534
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of hepatitis A vaccination in Indonesia.
Suwantika AA; Beutels P; Postma MJ
Hum Vaccin Immunother; 2014; 10(8):2342-9. PubMed ID: 25424941
[TBL] [Abstract][Full Text] [Related]
10. Cost-effective analysis of hepatitis A prevention in Ireland.
Rajan E; Shattock AG; Fielding JF
Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
[TBL] [Abstract][Full Text] [Related]
11. Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program.
Martínez A; Broner S; Sala MR; Manzanares-Laya S; Godoy P; Planas C; Minguell S; Torner N; Jané M; Domínguez A; For The Study Of The Immune Status In Health Care TW; Hepatitis A In Catalonia FT
Hum Vaccin Immunother; 2015; 11(1):192-7. PubMed ID: 25483535
[TBL] [Abstract][Full Text] [Related]
12. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
Bryan JP; Nelson M
Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
[TBL] [Abstract][Full Text] [Related]
13. The Financial Burden of Public Health Responses to Hepatitis A Cases Among Food Handlers, 2012-2014.
Morey RJ; Collier MG; Nelson NP
Public Health Rep; 2017; 132(4):443-447. PubMed ID: 28609202
[TBL] [Abstract][Full Text] [Related]
14. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).
Postma MJ; Bos JM; Beutels P; Schilthuis H; van den Hoek JA
Vaccine; 2004 May; 22(15-16):1862-7. PubMed ID: 15121296
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis A immunisation in persons not previously exposed to hepatitis A.
Irving GJ; Holden J; Yang R; Pope D
Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD009051. PubMed ID: 22786522
[TBL] [Abstract][Full Text] [Related]
16. Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response.
Mayorga O; Bühler S; Jaeger VK; Bally S; Hatz C; Frösner G; Protzer U; Van Damme P; Egger M; Herzog C
J Infect Dis; 2016 Nov; 214(10):1498-1506. PubMed ID: 27601623
[TBL] [Abstract][Full Text] [Related]
17. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees.
Purcell RH; D'Hondt E; Bradbury R; Emerson SU; Govindarajan S; Binn L
Vaccine; 1992; 10 Suppl 1():S148-51. PubMed ID: 1335648
[TBL] [Abstract][Full Text] [Related]
18. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin.
Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W
J Infect Dis; 1993 Sep; 168(3):740-3. PubMed ID: 8394864
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile.
Valenzuela MT; Jacobs RJ; Arteaga O; Navarrete MS; Meyerhoff AS; Innis BL
Vaccine; 2005 Jul; 23(32):4110-9. PubMed ID: 15964479
[TBL] [Abstract][Full Text] [Related]
20. Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis.
Shouval D; Ashur Y; Adler R; Lewis JA; Armstrong ME; Davide JP; McGuire B; Kuter B; Brown L; Miller W
Vaccine; 1993; 11 Suppl 1():S9-14. PubMed ID: 8383390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]